Wright State University

CORE Scholar
Master of Public Health Program Student
Publications

Master of Public Health Program

2011

Evidence-based Public Health Practices for Screening for
Postpartum Depression
Roula Hilli
Wright State University - Main Campus

Follow this and additional works at: https://corescholar.libraries.wright.edu/mph
Part of the Community Health and Preventive Medicine Commons

Repository Citation
Hilli, R. (2011). Evidence-based Public Health Practices for Screening for Postpartum Depression. Wright
State University, Dayton, Ohio.

This Master's Culminating Experience is brought to you for free and open access by the Master of Public Health
Program at CORE Scholar. It has been accepted for inclusion in Master of Public Health Program Student
Publications by an authorized administrator of CORE Scholar. For more information, please contact librarycorescholar@wright.edu.

Running Header: EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD

Evidence-based Public Health Practices for Screening for Postpartum Depression

By Roula Hilli

The following manuscript is submitted for partial fulfillment of the requirements of a
Master of Public Health Degree at Wright State University

EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD
Acknowledgements
I would like to thank all the people who helped me in this project, my supervisor Dr. Bill Spears,
Dr. Cristina Redko and Dr. Sara Paton for being my CE readers. Last but not least I would like to
thank all the faculty members in Wright State University’s Public Health Program for helping me
completing this master’s degree.

EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD
Table of Contents
Abstract .........................................................................................................................................2
Introduction...................................................................................................................................3
Purpose Statement.........................................................................................................................3
Literature Review..........................................................................................................................4
Research Question ......................................................................................................................18
Methods.......................................................................................................................................18
Results and Data Analysis ..........................................................................................................23
Discussion ...................................................................................................................................29
Conclusion and Recommendation ..............................................................................................32
Limitations of the Study..............................................................................................................32
References...................................................................................................................................33
Appendices..................................................................................................................................46
Appendix 1 – List of Included Studies ...........................................................................46
Appendix 2 - Edinburgh Postnatal Depression Scale (EPDS) ........................................47
Appendix 3 - PHQ-9 for Adults (Public Health Questionnaire).....................................49
Appendix 4 – List of Public Health Competencies Met .................................................50

1

EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD

2

Abstract
Background: Five to 20 percent of the women worldwide suffer from Post Partum depression
(PPD) which has serious negative impacts on the mother and her newborn. Although PPD is a
preventive disease thorough screening using different tools, half of its cases are left undetected.
Purpose of the study: Is to find the best practice for PPD screening, which includes the
best screening tool, best setting for screening, best administration period and the best cut-off
score.
Methods: It is an Evidence-based Public Health (EBPH) review through a comparative
study of 82 studies since 2005 that screened women for PPD in the postnatal period. All the
articles were extracted from Pub Med, and each one used a definite screening tool for PPD.
Results: Fifteen research articles reported on 82 studies that met study inclusion criteria.
Six different screening tools were used in these studies. The most commonly used screening tool
was EDPS (46 of 82 studies). Postpartum Depression Screening was conducted most often in in
perinatal clinics (44 studies). Screening was most often administered around six weeks after
delivery (57 of 82 studies). No consistent preferred cut-off score for positive PPD findings could
be identified for the SPDS because the sensitivity and specificity was not consistent across the
studies.
Conclusion: The best practice for PPD screening is to use EPDS as screening tool for
PPD around six weeks postnatal at a postnatal or prenatal maternity clinic.
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Introduction
With all the excitement that accompanies the impending arrival of a new baby and with
all the expected happiness the mother will have, there is unfortunately, an increase risk of
depression among new mothers. It is possible that the new mother may be affected by Post
Partum Depression (PPD). PPD affects 5%-20% of the women worldwide during the postpartum
period (Miller, 2002).
PPD is a major depression that occurs within the first 4 weeks after delivery and lasts for
at least two consecutive weeks. The strongest predictor factor for PPD is antenatal depression
(Leigh & Milgrom, 2008). Other risk factors are a previous depressive illness, life stress, lack of
social support, psychological factors, marital dissatisfaction, obstetric factors, and low
socioeconomic status (Robertson, Grace, Wallington, & Stewart, 2004).
PPD is different than normal depression because of the potential impact on the infant, the
family as well as the mother. Untreated maternal depression is associated with disruptions in the
infant’s cognitive (poor infant mental and motor development), emotional, and behavioral
development. The infant may develop eating and sleeping problems, separation difficulties and
temper tantrums (Csatordai et al., 2007).
Early detection of PPD can’t be achieved in a routine antenatal exam. A special
assessment that can detect high risk women is required. Primary prevention of PPD by early
detection of high risk women and treatment is effective in reducing the undesirable outcomes
that impact infants and result in restoring the mother to a healthy condition (Oppo et al., 2009).
Purpose Statement
The purpose of this study is to find the optimal evidence-based public health practices for
postpartum depression screening.
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Literature Review
Postpartum Depression
The postpartum period is important for the new mother, her newborn and her family.
Everyone expects this to be a time of joy and happiness for the family. With the new arrival it is
usually so, but it is also a time when the mother faces new challenges of being a mother. She
tries to meet the needs of her newborn, to adapt to the changes in her sleep pattern (most often
the lack of sleep), and to physically recover from the delivery. All these factors put the new
mother at risk for psychological distress during the postpartum period. Glavin, Smith, Sørum,
and Ellefsen (2010) mentioned three types of postpartum physiological problems: postpartum
blues, postpartum depression, and postpartum psychosis. Postpartum blues is the less severe
problem and affects 50 to 80% of mothers. It starts one to five days after delivery and is
manifested by fatigue, crying and emotional sensitivity. The most severe problem is postpartum
psychosis which affects 0.1% to 0.2% of new mothers during the first week following delivery.
These women usually have delusional thoughts, hallucinations and severe emotional distress
(Engqvist, Ahlin, Ferszt, & Nilsson, 2010). Between postpartum blues and postpartum psychosis
there is postpartum depression (PPD). The prevalence rate of PPD is 7% to15%. The causes and
risk factors for PPD are the same as for the depression outside the postpartum period. Risk
factors include history of depression, stress, lack of social support and low socioeconomic status.
PPD affects the health of the mother and her newborn, as well as her relationship within the
family (Goodman, 2004). Usually the woman suffers from insomnia, fatigue, and low selfesteem. The mother may suffer an inability to take care of her new baby either emotionally or
physically which affects the infant’s attachment to his mother and may lead to cognitive and
emotional problems during childhood. The high prevalence of PPD plus its wide range of effects
makes PPD as a public health issue, but the good news about this disease is that it can be
identified by screenings for the condition and treated before it reaches advanced stages. There
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are many instruments and questionnaires that have been proven to be good screening tools. The
Edinburgh Postnatal Depression Scale is the most widely used depression screening instrument
(Hewitt et al., 2010).
Postpartum depression definition and symptoms
Depending on the definition used the prevalence of PPD ranges between 0.5 – 60.8
percent worldwide. PPD as defined by DSM-IV is a major depressive disorder that starts within
the first four weeks after delivery (DSM IVTR; APA, 2000), while it is defined by ICD-10
(International Statistical Classification of Diseases and Related Health Problems) (WHO, 2007)
as a mild mental and behavioral disorder that begins within 6 weeks of delivery.
The clinical manifestations of PPD include depressed mood, insomnia or hyper insomnia,
feelings of worthlessness , loss of energy, markedly diminished pleasure in almost all activities,
significant change in weight (weight loss or gain), psychomotor agitation or retardation,
excessive guilt, reduced self-esteem and self-confidence, difficulty in concentration, and suicidal
ideation (APA, 2000; WHO, 2007). The severity of depression after giving birth varies among
women; it can be anything from postnatal blues (short and frequent symptoms of depression)
(Edhborg, 2008), to severe psychosis with suicidal thoughts (Noble, 2005; Paulson, Dauber, &
Leiferman, 2006).
Etiology of postpartum depression
Women are twice more likely to have major depressive disorder than men (Kessler, Chiu,
Demler, Merikangas, & Walters, 2005) and men usually do not suffer from PPD (Munk-Olsen,
Laursen, Pedersen, Mors, & Mortensen, 2006) suggest that genetic factors and the female
physiology system may be related to PPD. It is well documented that there are hormonal changes
after delivery due to the rapid fall in estrogen and progesterone level and that these changes can
lead to depressive mood (Paulson et al., 2006). While (Gleicher, 2007) pointed out to the
possibility that PPD is an autoimmune disease depending on the new theory which says that
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autoimmune disease is a result of the passage of fetal-maternal microorganisms (Gleicher, 2007)
in the two directions. But Ross, Murray, and Steiner (2005) found that sleep disturbance and the
change in the quality and quantity of the sleep after giving birth may be a cause of PPD not a
consequence of it, his theory was first introduced by (Karacan, Williams, Hursch, McCauley, &
Heine, 1969) and after that was supported with many studies (Frank, Kupfer, Jacob, Blumenthal,
& Jarrett, 1987; Coble et al., 1994; Lee, McEnany, & Zaffke, 2000).
Impact of postpartum depression
PPD is unique in the fact that it can affect the mother, her baby and as well as the whole
family. Having a new baby should be a pleasant time for the mother and her family; this is not
always the case. The mother may suffer from depression which could affect her connection with
the new baby and could decrease her ability of taking care of the baby. This has the potential to
result in feelings of guilt and hopelessness. Having PPD can increase the mother’s susceptibility
to smoke and to abuse alcohol and drugs. The risk for physical, emotional and sexual abuse is
also elevated because the women are more vulnerable to different types of abuse during this
period. Fairbrother and Woody (2008) found also that women with PPD may be more likely to
have intense thoughts of either accidentally or intentionally hurting the baby. PPD may have
long-term influences on the mother-infant relationship and on child development; this effect is
gender- specific as male infants are more affected by maternal depression than female infants.
When the interaction between the mother and her infants is affected by PPD the result can be
lower cognitive functioning and emotional problems (Tronick & Reck, 2009).
Untreated maternal depression affects the mother’s ability to take care of her new baby.
She is less likely to respond to the baby’s cues. The mother’s parental behaviors are affected by
depression with things such as feeding the baby, sleep patterns, breast feeding and paying
attention to safety habits. The mother’s depression, if left untreated, may result in her children
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suffering from psychiatric problems such as anxiety and affective disorders during their
childhood (Csatordai et al., 2007).
Risk factors for postpartum depression
Risk factors for PPD fall into different categories: strong, strong-moderate, moderate, and
mild. Experiences of depression or anxiety during pregnancy or a previous depressive illness are
the strongest risk factors (Robertson et al., 2004). Early detection and treatment of depression
during pregnancy is very critical, as untreated cases can develop to postpartum depression with
its negative outcomes on the mother and her baby (Ryan, Milis, & Misri, 2005).
Johanson, Chapman, Murray, Johnson, and Cox (2000) reported that one third of PPD
cases progress though a continuum of depression during pregnancy. Josefsson, Berg, Nordin, and
Sydsjo (2001) followed 417 women during pregnancy until 6 weeks after birth that the rate of
depression decreased from 17% during late pregnancy to 13% at week 4-6 after delivery.
Life stress and lack of social support have a moderate to severe influence on PPD
(Robertson et al., 2004). Robertson, Grace, Wallington, and Stewart (2004) said that women who
experience two or more stressful life events the year before pregnancy are more likely
predisposed to PPD. Stressor events are life experience such as death of a family member, loss of
one’s job, moving, and a chronic disease diagnosis. Social support is usually having people
available who can offer help to the mother taking care of her new baby and who can support her
emotionally during the pregnancy and at postpartum period (Pope, Watts, Evans, McDonald, &
Henderson, 2000); while lack of social support has negative impact on the mother and increases
her risk for PPD (Honey, Morgan, & Bennett, 2003).
Psychological factors have a moderate effect (Robertson et al., 2004). Mothers with low
self esteem (Ritter, Hobfoll, Lavin, Cameron, & Hulsizer, 2000), those who are perfectionist and
those who have high interpersonal sensitivity are more likely to develop PPD (Boyce, Parker,
Barnett, Cooney, & Smith, 1991). Obstetric factors and socioeconomic status have a small effect
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on PPD (Robertson et al., 2004). A history of miscarriages or terminations of pregnancies can
increase the mother’s risk for PPD (Pope et al., 2000; Robertson et al., 2004). Low
socioeconomic status and low educational attainment also have small impacts on PPD (Patel,
Rodrigues, & DeSouza, 2002; Tammentie, Tarkka, Astedt-Kurki, & Paavilainen, 2002).
Depression during pregnancy and family history of depression: Depression during
pregnancy results in negative consequences for both the baby and the mother. Depression during
pregnancy is associated with a three to fourfold increase in PPD within six month after delivery
(Oppo et al., 2009). It can lead to preterm birth, increasing in smoking behavior, deteriorating of
social function and emotional withdrawal which are themselves predisposing factors for PPD
(Bowen & Muhajarine, 2006). Robertson and colleagues (2004) found that depression during
pregnancy is a strong predictor of postpartum depression. This supports the hypothesis that
postpartum depression is a continuation of major depression that occurred during pregnancy.
Kumar and Robson (1984) reported that other studies found that major depressive symptoms can
occur prenatal and not reoccur in the postnatal period or can start in the postpartum period
without having experienced depression during pregnancy. These studies suggest that antenatal
and postpartum depressions are distinct disorders. While it is well confirmed that major
depression disorder is familial, it cannot be confirmed that genetic factors predispose women to
PPD (Murphy-Eberenz et al., 2006).
Postpartum depression and anxiety: Anxiety is considered a normal consequence of the

physiological and psychological changes during pregnancy especially if the anxiety is related
toward the health of the baby and the concerns about being a mother, such as the new tasks
associated with taking care of the baby and at the same time maintaining the perfect image as a
mother of other children if she has other children. These concerns may also extend to her role as
a wife. A history of anxiety during the first trimester is not a predictor for PPD. However, in
some cases anxiety can be related to panic disorder which is a strong predictor of PPD. A history

EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD

9

of panic disorder during the first trimester of pregnancy increases the chance of PPD by 4.2
times. If the mother has a family history of panic disorder the risk for PPD is 2.1 times as high.
Rambelli and colleagues (2010) said that panic disorder should be identified and treated as a
measure to prevent the development of PPD. Anxiety during pregnancy is twice as common as
depression, but depression in the postpartum period is twice as common as anxiety (Heron,
O’Connor, Evans, Golding, & Glover, 2004). While studies found that a history of anxiety
during the first trimester is not a predictive factor for PPD, Sutter-Dallay, Giaconne-Marcesche,
Glatigny-Dallay, and Verdoux (2004) found at their MATQUID cohort study that women with a
history of anxiety disorder during third trimester are three times more likely to experience PPD.
Postpartum depression and smoking: Both smoking and PPD are maternal and treatable
conditions that have adverse effects on the mother and her newborn. Smoking is associated with
increasing the infant’s risk for sudden infant death, low birth weight, attention
deficit/hyperactivity disorder, asthma, and otitis media (National Cancer Institute, 1999,
Milberger, Biederman, Faraone, Chen, & Jones, 1996). Many researches had been found that
smoking is associated with increased incidence of postpartum depression (Bryan, Georgiopoulos,
& Harms, 1999). A study that surveyed 4,353 women 15 months after delivery found that the
prevalence of a major depressive episode is higher among smokers (17.7%) than nonsmokers
(12.1%), smoking was also more common among mothers who have experienced a major
depressive episode than in those without one: 34.0% vs. 25.5%, so when these two conditions
co-occur they have to be treated at the same time (Whitaker, Orzol, & Kahn, 2007). Research
studies had found that smoking can cause preterm delivery and low- birth weight infants which
in turn can increase the risk of PPD support, lack of education, low income and smoking which
are also risk factors for PPD (Gungor, Oskay, & Beji, 2011).
Postpartum depression and social support: Social support is defined as the interpersonal
resources that are accessed and mobilized when individuals attempt to deal with the everyday
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stresses and strains of life (Chen, Tseng, Wang, & Lee, 1994). The research studies found that
Lack of social support is associated with increased risk of PPD. Several studies pointed out that
social support can reduce bad behaviors among women at the postpartum period as smoking and
drug abuse (Brugha et al., 1998; Collins, Dunkel-Schetter, Lobel, & Scrimshaw, 1993). Support
is usually provided by the husband or partner through emotional support, a family member by
taking care of the baby or hospital personnel by giving advice regarding nursing the baby and
taking care of his hygiene.
Cultural activities during pregnancy vary between populations. Cultural practices could
help in decreasing the chance of PPD or they could increase it. Many cultures have different
ideas about how to deal with the confinement period following the birth. Some societies consider
this time as an individual and private time and they leave the new mother alone to deal with the
new baby as is the custom in western culture. In eastern culture there is a wide interference with
the new mother and her newborn daily life; usually mother or mother-in-law determines the food
the mother will eat, the time of the mother’s bath, and the way she and her baby dress (Wan et
al., 2008).
In eastern culture the families of the new parents play an important role during the
confinement period which is usually lasts up to 40 days after delivery. The new mother usually is
able to rest physically during this time. There is someone who is taking care of the mother’s
needs, the baby’s needs, and the housework. It is also a time when a lot of people come to
congratulate the new mother, but at the same time the trade-off is that they interfere with every
single detail in her behavior regarding taking care of herself and her baby. How the mother
tolerates the ritual confinement period may improve interpersonal relationships and enhance the
health of the women, or it may be perceived as violations of privacy and the mother’s time with
the baby (Klainin & Gordon, 2009).
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In some cultures, as in Turkey, giving birth is a protective factor against depression
because the level of social support the mother usually receives at this period which include the
physical and emotional respect; women in Turkey usually stay resting after birth while many of
her family members take care of the home chores and the newborn needs, they also throw parties
to appreciate her and to welcome the baby (Kara, Unalan, Cifcili, Cebeci, & Sarper, 2009). In
China the social support the new mother gets during the first month after delivery, which is
usually called Zuoyuezi, could double the risk of PPD if it is provided by the mother in law. The
mother-in-law has a lot of power over her daughter-in-law. Often she uses this power to control
the life of her daughter-in-law in the postpartum period and to impose more pressure on the new
mother. This pressure can increase the chances the mother will experience depression (Wan et
al., 2009).
Postpartum depression and violence: Violence during pregnancy affects the physical and
mental health of the mother and it also affects the health of the baby (Romito, Pomicino,
Lucchetta, Scrimin, & Turan, 2009). Cohen, Schei, Ansara, Gallop, and Stewart (2002) found
that only emotional abuse plays a role in elevated the risk of PPD, sexual or physical abuse do
not increase the risk of PPD. Violence during the postpartum period is more common than during
pregnancy. The rate of violence during pregnancy varies worldwide between 6% and 17%. The
risk factors for partner violence are almost the same as the risk factors for post-partum
depression. These include: financial dissatisfaction, migration status, unwanted pregnancy and
being unemployed (Saurel-Cubizolles & Lelong, 2005; Saltzman, Johnson, Colley, & Goodwin,
2003).
Postpartum depression and socioeconomic status: Many studies around the world had
been conducted to find the impact of income, educational level and employment status on the
occurrence of PPD. The influence of low income increasing the chances of PPD was confirmed
in some studies in the USA (Segre, O'Hara, Arndt, & Stuart, 2007), Brazil (Tannous, Gigante,
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Fuchs, & Busnello, 2008), and Turkey (Gulseren et al., 2006). In other studies in the USA
(Goyal, Gay, & Lee, 2010) and Japan (Miyake, Tanaka, Sasaki, & Hirota, 2011) found that low
income does not increase the chance of PPD. There are also different results for the association
between employment status and the incidence of PPD; some studies found that full employment
job reduces the occurrence of PPD (Mayberry, Horowitz, & Declercq, 2007). Others confirmed
that employment status does not have any role in increasing the possibility of PPD (Goyal et al.,
2010). While Patel, Rodrigues, and DeSouza (2002) reported that in India full time employment
increases the risk for PPD. Although there was no agreement among the research studies
regarding the impact of income and employment status on the occurrence of PPD, there was an
agreement regarding the effect of educational level; they found that educational level does not
increase or decrease the risk of PPD (Goyal et al., 2010; Miyake et al., 2011). But one interesting
result comes from the result of the prospective study in Japan (Miyake et al., 2011) which
claimed that holding a high prestigious job (which is associated with a high level of education) is
a protective factor against PPD.
Postpartum depression and parity: Although research studies found an association
between multiparty and depression during the third month of pregnancy (Borri et al., 2008), no
difference in the rates of PPD were found between multiparous and primiparous women.
Multiparous women had more risk factors for PPD such as lack of social support, previous
depression, marital dissatisfaction and low self esteem than primiparous women. But multiparous
women receive more psychological and drug treatment for depression (Oppo et al., 2009).
Postpartum depression and lack of sleep: Sleep disturbance is very common during the
post-partum period because of the newborn pattern of feeding and sleep. Although there is an
association between lack of sleep and PPD, the relationship is not fully documented, because of
the ambiguity of the definitions of the terms (Hunter, Rychnovsky, & Yount, 2009).
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Postpartum depression and infant health: Delivery before 37 weeks of pregnancy is
called preterm birth. It has been proven that pre-term infant is associated with higher risk for
PPD. At the same time it is well known that pre-term is associated with low social support, lack
of education, low income and smoking which are also risk factors for PPD (Gungor, Oskay, &
Beji, 2011).
Treatment for Postpartum Depression
Usually there is a delay for the treatment for PPD because mothers do not like to admit
they have psychological symptoms due to the social shame of a possible psychiatric illness.
Mothers also do not realize that they are sick but their symptoms instead contribute their feeling
of failure as a mother.
Treatment of PPD is similar to the treatment of depression outside the postpartum period,
except for additional concerns during this period; concerns of breastfeeding, hormonal changes
after delivery and the fear of being separated from their baby if they get a treatment (Oppo et al.,
2009).
Pharmacological treatment
Antidepressants
No difference in the mother’s response for antidepressant medication was found during
postpartum period and outside of this period (Payne, 2007; Pearlstein, Howard, Salisbury, &
Zlotnick, 2009). Many open- label studies have been conducted and shown the effectiveness of
many types of antidepressants for PPD; venlafaxine (Cohen et al., 2001), sertraline (Stowe &
Nemeroff, 1995), bupropion (Nonacs et al., 2005), fluvoxamine (Suri, Burt, Altshuler,
Zuckerbrow-Miller, & Fairbanks, 2001) and paroxetine (Misri, Reebye, Corral, & Milis, 2004).
Antidepressants and breast feeding
The importance of breastfeeding for the health of the mother and the baby is well known.
As a result the American Academy of Pediatrics recommends that mothers have to breastfeed
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their babies. However a big concern is when we will treat a breastfeeding mother with any
medication in general and with antidepressants in particular due to scarce data regarding safety.
Eberhard-Gran, Eskild, and Opjordsmoen (2006) found a low number of reported adverse effects
when using tricycles and SSRIs during breastfeeding. Many considerations have to be taken as a
safety procedures while taking antidepressants, for instance, taking the medicine after
breastfeeding and before sleeping , using medication that was effective during previous episodes
of depression, using the same medication that was used during pregnancy because the infant had
been already exposed to that medication; and finally, the family member has to be familiar with
the side effects of the medication on the infants such as sleep and agitation (Payne, 2007).
Hormonal treatment
Use of hormone treatment can be effective because the change in the estrogen and
progesterone during the postpartum period can be responsible for the maternal mood changes
(Moses-Kolko, Berga, Kalro, & Wisner, 2009).
Non-pharmacological
Some mothers find non-pharmacological treatments desirable if they breastfeed their
infants. This includes psychological and psychosocial treatments; both these treatments were
found to be effective in decreasing post-partum depression (Dennis & Hodnett, 2007).
Psychological treatment includes Interpersonal Therapy (IPT) and Cognitive Behavioral
Therapy (CBT) while psychosocial treatments include nondirective counseling and peer and
partner support (Fitelson, Kim, Baker, & Leigh, 2011).
Screening for post-partum depression
Screening for PPD is very useful in identifying women at risk for PPD. Women who are
identified as high risk should be offered appropriate treatment and prevention strategies to reduce
the chance of occurrence of PPD and the negative outcomes that will affect the mother and her
baby. There are 13 instruments that are used to assess the increase risk of PPD. Screening
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instruments are considered to be a good prevention tool to help identifying women with high risk
factor for PPD during their pregnancy or in the postpartum period (Oppo et al., 2009).
These instruments are:
1.

Beck Depression Inventory (BDI)

2.

Beck Depression Inventory (BDI-II)

3.

Bromley Postnatal Depression Scale (BPDS)

4.

Center for Epidemiologic Studies Depression Scale (CES-D)

5.

Clinical Interview Schedule (CIS)

6.

Diagnostic Interview Schedule (DIS)

7.

Edinburgh Postnatal Depression Scale (EPDS)

8.

General Health Questionnaire (GHQ)

9.

Inventory of Depressive Symptomatology (IDS)

10.

Postpartum depression Screening Scale (PDSS)

11.

Zung Self-Rating Depression Scale (Zung SDS)

12.

Pregnancy Health Questionnaire (PHQ)

13.

Pregnancy Health Questionnaire-9 (PHQ-9)

14.

Two question screen of the PHQ

The most commonly used screening instruments for PPD are:
Edinburgh Postnatal Depression Scale (EPDS)
EDPS is designed to assess post-partum depression. It was first designed for use by
women who speak English. It has subsequently reached non-speaking English countries. It is a
self-report instrument which has 10 items. Items written in the past tense include statements
relating to feelings mothers experienced in the past seven days and evaluate depressed mood,
anhedonia, guilt, anxiety and suicidal ideation. The EPDS is usually administered by the paper
and pencil method although computerized versions are available; it is brief, taking approximately
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5 minutes to complete, and easy to administer, score and interpret. It is a self-report instrument
which has 10 items. The range of scores is from 0 to 30. A score above 12 suggests a high
possibility the woman is experiencing PPD. EPDS has a high specificity and sensitivity
(Adewuya, Eegunranti, & Lawal, 2005). It is necessary to consider that the cut-off score should
be set at different levels for different countries (Nishimura & Ohashi, 2010). The EPDS is used
to evaluate postpartum depression at birth and at six, 12, 18 and 24 weeks post-partum (Boyce &
Hickey, 2005).
Postnatal Depression Screening Scale (PDSS)
The PDSS is a postpartum depression screening tool that can identify women who could
suffer from PPD. It is a 35-item Likert-type response scale that can take 5 to 10 minutes to
complete; it is brief and easy to understand and interpret. The PDSS consists of seven
dimensions (each of them contains five items). The dimensions include sleeping and eating
disturbances, anxiety/insecurity, emotional liability, cognitive impairment, loss of self,
guilt/shame, and thoughts of self-harm. Each item describes the type of feelings a woman may
experience after the birth of a child. Mothers are asked to indicate their feelings on a 5-point
scale ranging from ‘strongly agree’ to ‘strongly disagree’ regarding how they have felt in the last
2 weeks. Scores of 80 or above indicate major depressive disorder while 60 or above indicate
minor depression disorder. It has a sensitivity of 91% to 94%, specificity of 72% to 98% and a
positive predictive value of 33% to 88%.
Beck Depressive Inventory (BDI)
The BDI instrument contains 21 items related to particular symptoms of depression in the
last week. Even though this is a general depression scale it has been used frequently with
pregnant and postpartum women (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). Each item
is scored from zero to three in terms of intensity where (0) I do not feel sad, (1) I feel sad, (2) I
am sad all the time and I can't snap out of it, (3) I am so sad or unhappy that I can't stand it. The
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total score of the 21 items is interpreted as follows: 0 to 9 indicates minimal depression, 10 to 18
indicate mild depression, 19 to 29 indicate moderate depression, 30 to 63 indicate severe
depression, and higher scores indicate more severe depression (Beck et al., 1961).
Beck Depressive Inventory-II (BDI-II)
In response to the change of many of the diagnostic criteria for Major Depressive
Disorder by the American Psychiatric Association's publication of the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, A new version of BDI was created in 1996, this
version is BDI-II. In this revision some items were replaced (changes in body image,
hypochondria, and difficulty working), some were revised (sleep loss and appetite loss items),
and some remained the same (items dealing with feelings of being punished, thoughts about
suicide, and interest in sex). Also as opposed to ask about the feelings in the past week as in the
original BDI, participants were asked to rate how they have been feeling for the past two weeks.
BDI and BDI-II both contain 21 questions, each answer scores on a scale value of 0 to 3.
The cut-off scores used in BDI-II differ from the original BDI: 0 to 13 indicates minimal
depression; 14 to 19 indicate mild depression; 20 to 28 indicate moderate depression; 29 to 63:
severe depression and higher total scores indicate more severe depressive symptoms.
(General Health Questionnaire) GHQ 12
GHQ (Goldberg, 1972) is a self-administered questionnaire that has 60 items; it is
originally used to detect common mental disorder such as anxiety and depression among general
medical patients. GHQ-12 is GHQ version that has 12 items of the 60 original items; it evaluates
the response for each item using a four-level alternative response scale and the total score ranges
from zero to 12. Boyd, Le, and Somberg (2005) recommended the 12-item GHQ to detect
postpartum depression because this version is the shortest type of GHQ and has a slightly higher
sensitivity and positive predictive value. Among general population, GHQ 12 has76% sensitivity
and 80% specificity at the optimal cut-off score of 2/3 (Lobo & Muñoz, 1996; Oppo et al., 2009).
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Patient Health Questionnaire 9 (PHQ-9)
The PHQ-9 is a nine-item self-report depression screening tool that evaluates symptoms
experienced during the past 2 weeks (Kroenke, Spitzer, & Williams 2001). Each item includes
four possible responses that correspond to the duration of the symptoms. There are two scoring
methods for PHQ-9: summary scoring algorithm and a diagnostic algorithm. In the summary
scoring (simple scoring), scores ≥10 of a scale range 0 to27 are often used to screen for major
depression (Kroenke & Spitzer, 2002). The PHQ-9 diagnostic algorithm scoring (complex) is
based on DSM-IV depression diagnostic criteria (Spitzer, Kroenke, & Williams, 1999). Patient
must have at least five depressive symptoms at least “more than half of the days” and at least one
of those must be depressed mood or loss of interest.
Research Questions
This study the best practices for PPD screening. These practices include the best
screening tool depending on the most common used tool and the best sensitivity and specificity,
the best time and setting for screening, and the best cut-off score. There are 13 screening tools
for PPD used in various settings around the world; six of these are most commonly used. This
study is designed to identify the screening instrument that is best identifying for depression
among women during the postnatal period.
Methods
According to Brownson, Fielding, and Maylahn (2009), one key component of Evidencebased Public Health (EBPH) is to make decisions based on the best available scientific data. This
study is an EBPH review in which an analysis of Post Partum Depression (PPD) using published
literature is provided. Pub med, WSU library and Ohio LINK were searched for articles using the
following search terms: antenatal depression, postnatal depression, postpartum depression,
screening, prevention, and best practices. In addition, the references cited in the published
articles were searched, and those which appeared relevant were also retrieved.
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Criteria for the selection of studies: To be included in this analysis, a study had to meet
all of the following criteria:
1. Women were screened for PPD using at least one of the 13 validated screening tools
for PPD.
2. Women were screened during the postnatal period (from birth until 18 month after
delivery).
3. The diagnostic criteria of PPD for the study were based on the DSM-IV, DSM-III
and International Classification of Diseases (ICD-10). The study was published in
2005 or later.
4. The study was written (or translated) in English.
The requirement that studies be published in 2005 or later insured that findings are based
on the most current research. The studies in this research were not restricted to a specific location
or country; all international studies that met the criteria for inclusion were included. It was not
necessary to exclude articles based on sample size; the minimum sample size in the studies was
104. Studies reviewed for this research include all women in the child bearing ages (15 to 44).
All settings in which screenings were conducted were included in this study. Screening
can be done at a variety of locations, including primary care physician’s office, OB/GYN
physicians’ office, pediatrician’s office, and health departments or even by phone, or in the
patient’s home. Studies were reviewed to ensure that a rigorous protocol was used to screen
mothers and confirm the mothers would be able to understand all the questions in the
questionnaire. It was not necessary that the person who administered the screening instrument be
physician or a psychiatrist, only that he or she had the ability to ask the questions clearly and to
record results correctly.
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Types of screening: Each study used at least one PPD screening instrument during the
postnatal period to classify women as either at risk or not at risk of postnatal depression, on the
basis of reliable diagnostic criteria.
Study measures: The following characteristics of the screening instrument were sought:
1.

The title of screening instrument(s) used in each study was recorded.

2.

Cut-off score: Most of the instruments used more than one cut-off score to
determine which participants are at risk for PPD.

3.

Sensitivity and specificity: Sensitivity of the screening instrument is an essential
outcome measure examined in this analysis. Sensitivity and specificity rates for
each cut-off score for an instrument were recorded for each article.

4

Time of the screening: the time within the postnatal period in which screening was
conducted was recorded for each study.

Calculated Measures
Sensitivity of the screening instrument is an essential outcome measure used to analyze
the usefulness of screening tools in detecting whether women have PPD. Sensitivity is defined as
the ratio between those patients who test positive and all those patients who actually have the
disease, whether their tests are positive or false negative. Most studies reported the sensitivity of
each screening tool. If the sensitivity was not available it was calculated using this formula:
Sensitivity = TP / (TP+FN), where TP is the number of true positives (the patient screened
positive for PPD and received a PPD diagnosis). FN is the number of false negatives (the patient
screened negative for PPD but received a PPD diagnosis).
Specificity of the screening instrument is another essential outcome measure used to
analyze the effectiveness of screening tools. Specificity is defined as the proportion of patients
without the disease who test negative. Most of the studies reported the specificity for each
screening tool and for each cut-off score used for that tool. If the specificity was not available it
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was calculated using this formula: Specificity= TN / (TN + FP), where TN is the number of true
negatives (patient screened negative for PPD and did not receive a diagnosis of PPD). FP is the
number of false positives (patient screened positive for PPD but did not receive a diagnosis of
PPD).
Analytical criteria:
The data abstracted from each paper were tabulated using Microsoft Excel. Results were
collected by instrument and cut-off scores used to determine whether a woman was at risk of
PPD, the rate of depression in each study was reported. For each cut-off score for each
instrument the mean, median, the standard deviation, the range, the Number Needed for
Diagnosis NND and the Youden score were calculated for the specificity and sensitivity. In
addition, the mean, median and range of the maternal age and the rate of PPD were also
calculated.
Number needed to diagnose (NND) is a function of sensitivity and specificity, which are
tend to remain highly stable across populations. The NND indicates the number of tests that need
to be undertaken in order to get a positive diagnosis, its formula is:
NND=1/ [sensitivity-(1-specificity)]. It gives a comparison between tests. An optimal
NND value would be close to 1.0 (Batstone, 1997).
Youden index: It measures the effectiveness of a diagnostic marker and help in the
selection of an optimal cutoff point. It is calculated as (sensitivity +specificity-1); it has
minimum and maximum values of -1 and +1, with an optimal value +1 (Schisterman, Faraggi,
Reiser, & Hu, 2008).
A count was used to identify which screening tool was most commonly used. The
sensitivity and specificity for each tool and for each cut-off score used were evaluated based on
the mean and standard deviation.
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Criteria for determination of evidence-based screening practices:
The best screening tool for PPD: was detected depending on four criteria (chosen by the
author of this study):
1.

The best setting in which to screen for post-partum depression was determined by
reviewing the settings in which the instruments were used in each study. The most
commonly used setting across all the studies was identified as the best setting in
which to screen for post-partum depression.

2.

The best time-period in which to screen for post-partum depression was determined
by reviewing the time-periods in which the instruments were used in each study.
The most commonly used time-period across all the studies was identified as the
best setting in which to screen for post-partum depression.

3.

The most commonly used instrument was determined by reviewing the number of
times each instruments was used in peer reviewed research articles. The instrument
with the largest number of uses in studies is the most commonly used instrument.
The most frequently studied instrument was detected by the number of times each
instrument was used in the various studies. Several of the research projects used one
of the Post-Partum Depression Screening instruments more than once with different
cut-off scores to determine which score was the most successful for determining
whether a mother was at risk of PPD. The numbers of times each of the instruments
were studied across all the articles were summed. The instrument with the largest
number was considered most frequently studied instrument.

4.

The optimal cut-off score for the most commonly used screening tool: the sensitivity
of the screening tool is very important from a clinical perspective. If the screening
tool has a high sensitivity it can identify post-partum women who are depressed

EVIDENCE-BASED PRACTICES FOR SCREENING FOR PPD

23

(sensitivity). But at the same time it is important to not falsely identify post-partum
women as depressed when they are not (false positives). An increase in false
positive results in a decrease in the specificity. The most sensitive cut-off score was
identified by comparing the mean and the standard deviation of the sensitivities for
the instrument. The goal is to identify the cut-off score with the highest mean
sensitivity with the smallest standard deviation paired with the highest mean
specificity with the smallest standard deviation. The optimal sensitivity and
specificity is likely to not include the highest value for either measure.
Results
A total of 82 studies (published in 16 articles), met the inclusion criteria. Each of the
articles had at least one study depending on the number of screening tool and the number of
different cut- off point that had been used. A full list of included studies can be found in the
Appendix 1.
Postpartum Depression Screening Instruments
1. Most commonly used instruments
Six screening tools were evaluated in this research from the 16 articles reviewed. Some
articles used more than one screening tool in their research; these tools were Edinburgh Post
natal Depression (EPDS), Beck Depression Inventory (BDI), Beck Depression Inventory II
(BDI-II), Post-natal Depression Screening (PDSS), Pregnancy health Questionnaire (PHQ-9),
and General Health Questionnaire (GHQ-12).
Table 1 shows the screen tools and the number of studies in which the instrument was
used.
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Table 1. Evaluated Screening Tools and Number of Studies
Screening tool

Number of studies

EPDS

46

BDI

14

PDSS

8

GHQ-12

7

PHQ-9

4

BDI-II

3

EPDS was used 11 times across the 16 studies; it was studied 46 times in different studies
compared to the next most commonly studied instruments, the PDSS (12 times) and BDI (8
times). The EPDS was the most frequently used and most commonly studied screening tool.
2. Setting
Table 2 shows the setting in which the postpartum depression screening instruments were
across the different studies.
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Table 2. Setting for PPD Screening
Study and date

Country

Hospital Maternity Clinic
Jardi, 2006
France
Agoub, 2005
Morocco
Austin, 2005
Australia
Teng, 2005
Taiwan
Post-Natal/Perinatal Clinic
Navaro, 2007
Spain
Pitanupong, 2007
Thailand
Abiodun, 2006
Nigeria
Adewuya, 2005
Nigeria
Hanusa, 2006
USA
Navaro, 2007
Spain
Adewuya, 2005
Nigeria
Hanusa, 2006
USA
Hanusa, 2006
USA
Outpatient – Primary Care
Gjerdingen, 2009
USA
Flynn, 2011
USA
Flynn, 2011
USA
Chaudron, 2010
USA
Chaudron, 2010
USA
Chaudron, 2010
USA
Community Based Organization
Vittayanont, 2006
Thailand
Milgrom, 2005
Australia
Milgrom, 2005
Australia
Acute care Clinic
Beck, 2005
USA

Instrument

Number of
Uses

EPDS
EPDS
EPDS
BDI-II

7
4
1
3

16.1%
6.9%
5.2%
10.3%

EPDS
EPDS
EPDS
EPDS
EPDS
GHQ-12
BDI
PDSS
PHQ-9

8
7
7
6
1
7
6
1
1

25.4%
1.0%
18.6%
14.6%
11.0%
25.4%
14.6%
11.0%
11.0%

PHQ-9
PHQ-9
EPDS
EPDS
PDSS
BDI

2
1
1
1
1
1

8.9%
73.0%
73.0%
37.0%
37.0%
37.0%

PDSS
EDPS
BDI

6
3
3

1.0%
8.0%
8.0%

BDI

4

18.0%

PPD Rate

The setting of PPD screening had been done 44 times in post-natal/perinatal clinics, 15
times in hospital maternity clinics, 12 times in community based organization, seven times in
out-patient- primary care and four times in acute care clinics
Studies were undertaken in different countries:, 19 in Nigeria, 15 in Spain, 14 in USA, 13
in Thailand, 7 in France, 7 in Australia, 4 in Morocco and 3 in Taiwan. The diversity of cultures
in which studies were conducted may have an impact on the ability to compare results in
different circumstances.
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The EPDS was used in all of these countries except in Taiwan, where the local version
was used. EPDS had been translated to the local spoken language at each country where English
is not the spoken language.
3. Administration period
The administration period for PPD screening using EDPS was in a range from birth up to
56 weeks postnatal, 33 of the studies contracted patients in a window of time around six weeks
after delivery. Seven studies contacted patients between three to five days postpartum and one
study extended their screening period up to 56 weeks postpartum.
The administration periods for other screening tools in our study were almost at the same
range of EPDS. Administration periods for the studies that used BDI, BDI-II, PDSS, PHQ, and
GHQ-12 were in a range of two weeks and 56 weeks postnatal, where 24 studies contracted
around six weeks, four studies had an administration period between two and 12 weeks and two
studies had a long administration period from two weeks until 14 months, while three other
studies occurred at four month postnatal.
Table 3. Administration Period for PPD Screening
Study, Country, Year
Austin, 2005, Australia
Jardi, 2006, France
Beck, 2005, USA
Chaudron, 2010, USA
Hanusa, 2006, USA
Abiodun, 2006, Nigeria
Agoub, 2005, Morocco
Navarro, 2007, Spain
Pitanupong, 2007,Thailand
Vittayanont, 2006,Thailand
Adewuya, 2005, Nigeria
Teng, 2005, Taiwan
Milgrom, 2005, Australia
Gjerdingen, 2009, USA

PPD
Rate
5.20%
16.10%
18.00%
37.00%
11.00%
18.60%
6.90%
25.40%
1.00%
1.00%
14.60%
10.30%
8.00%
8.90%

Time of screening
32 weeks gestation, 2-4 month postnatal
3 to 5 days postnatal
2 to12 weeks postnatal
2 weeks to 14 months postnatal
6 to 8 weeks after birth
6 weeks postnatal
6 weeks, 6 and 9 months postnatal
6 weeks postnatal
6 to 8 weeks after birth
6 to 8 weeks after birth
6 weeks postnatal
6 weeks postnatal
4 months postnatal
N/A
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4. Cut-off scores and sensitivities and specificities
The recommended cut-off score for EPDS is 10, at this score women who are at increased
risk for PPD can be detected and at the same score there are a reasonable number of false
positive cases (Cox, Holden, & Sagovsky, 1987). To determine if a more optimal cut-off score
could be identified researchers tested the EPDS instrument using a wide range of cut-off scores
in efforts to determine the optimal cut-point to identify women at risk of postpartum depression.
In 45 studies in populations across the world cut-off scores between six and 14 were used. In
some cases decimal cut-off scores were used, these were rounded to the nearest whole number.
Table 4 shows the number of studies conducted using these cut-off scores and the average
sensitivity and specificity for studies that used a certain cut-off score. The sensitivity and
specificity for EPDS varied depending on the cut-off score considered and the population
studied. The table below is showing that the average of the sensitivity among different studies is
the highest at the cut-off score 6 (0.91) and it is the lowest at the cut-off score 14 (0.40). The
average of sensitivity decreased as the cut-off score increased. The exception was at the cut-off
score 13 which had an average sensitivity of 0.71 following a sensitivity of 0.61 for the cut-off
score of 12. The average specificity ranged from 0.61 to 1.00. The average of specificity was
increasing as the cut-off score was increasing except at the cut- off scores 11 and 13. The
Youden Index combines the sensitivity and the specificity scores to create a range from 0.00 to
1.00. The Youden Index for the EPDS cut-off scores ranges from 0.52 to 0.63. Analysis
demonstrates that due to the variability of sensitivity and specificity for cut-off scores there is no
score that provides a consistently high Youden Index.
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Table 4. Cut-Off scores used for PPD Screening with EPDS
Cut-off
score

Times
Used

Sensitivity

6
7
8
9
10
11
12
13
14

5
4
5
4
8
6
7
5
1

0.91
0.87
0.85
0.79
0.72
0.68
0.61
0.71
0.40

Sens
SD
0.10
0.13
0.11
0.13
0.15
0.22
0.22
0.20

Specificity

0.61
0.71
0.78
0.82
0.88
0.87
0.91
0.86
1.00

Spec
SD

Youden
Index

Youden
SD

0.13

0.52
0.59
0.63
0.61
0.60
0.56
0.51
0.58
0.40

0.15

0.17
0.14
0.10
0.08
0.15
0.10
0.20

NND

2.06
1.87
1.68
1.70
1.75
1.99
2.20
1.82
2.50

0.21
0.18
0.12
0.14
0.21
0.20
0.15

NND
SD
0.62
0.63
0.41
0.35
0.36
0.64
0.77
0.43

An optimal NND value would be close to 1.0. For the EPDS cut-off scores the NND
value range from 1.68 to 2.50. Consistent with Youden Index results the variability of sensitivity
and specificity values results in no NND values that suggest an optimal cut-off score for the
EPDS. Results in Table 5 confirm the lack of a consistent cut-off score across EPDS studies.
Four selected studies with Youden Indices and NND values close to 1.0 have a range of cut-off
scores from 8.5 to 12.
Table 5. Cut-Off scores used for PPD Screening with Selected EPDS Studies
Study

Adewuya, 2005
Agoub, 2005
Agoub, 2005
Agoub, 2005

Cut-off
Score

8.5
10
11
12

Sensitivity

Specificity

0.94
1.00
0.96
0.92

0.97
0.88
0.95
0.96

Youden
Index

0.91
0.88
0.91
0.88

NND

1.099
1.136
1.099
1.136

PPD Rate
The rate of PPD across the different studies ranged from 1% to 73% as shown in the
Table 6.
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Table 6. Post-Partum Depression rates for Cut-Scores used for PDSS Screening Instruments
Study, Country, Year
Austin, 2005, Australia

PPD Rate
5.2%

Milgrom, 2005, Australia
Jardi, 2006, France

8.0%
16.1%

Agoub, 2005, Morocco

6.9%

Adewuya, 2005, Nigeria

14.6%

Abiodun, 2006, Nigeria

18.6%

Navarro, 2007, Spain

25.4%

Teng, 2005, Taiwan

10.3%

Pitanupong, 2007, Thailand

1.0%

Vittayanont, 2006, Thailand

1.0%

Beck, 2005, USA

18.0%

Chaudron, 2010, USA

37.0%

Flynn, 2011, USA

73.0%

Gjerdingen, 2009, USA
Hanusa, 2006, USA

8.9%
11.0%

Yawn, 2009, USA

n/a

Discussion
PPD is the number one complication during the postpartum period (Coates, Schaefer, &
Alexander, 2004). Although in the last 50 years there has been a big advance in the prevention of
birth complications, the prevalence of PPD is still the same.
It is well known that half of the PPD cases are unrecognized (Georgiopoulos, Bryan,
Wollan, & Yawn, 2001). The barriers for the screening and treatment of PPD were identified and
it falls into two categories: 1) The patients’ barriers: which includes lack of knowledge about
signs and symptoms or about where they can seek help, the fear of medication if they are nursing
the baby, and the fear of looking an imperfect mother if they have depression, 2) providers’
barriers: Providers usually are primary care physicians, pediatricians and obstetric and
gynecologists. Their barriers include also lack of knowledge about the best screening tools,
signs, symptoms and treatment, in addition the restricted time and no compensation for the
provided services (Rosenfield, 2007).
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This study is aimed to decrease the undetectable number of PPD cases by finding the best
practices for approaching PPD screening. It is an evidence-based study where a systematic
review of published articles has been conducted.
Most commonly used instrument: Results showed that 46 studies out of 82 used an
EPDS as the PPD screening tool. EPDS is the most commonly used instruments across all
studies and it has been translated to different languages, these findings are consistent with the
findings of Hewitt et al. (2010). EPDS is brief, simple and takes about 5 minutes to complete. It
is easy to administer and score, which makes it a feasible instrument to be promoted into the
maternal and child care programs of Public Health Centers (Abiodun, 2006). Studies have also
showed that the EPDS performs better than the traditional PPD screening instruments as the
Beck Depression Inventory when used in postnatal period (Prichard & Harris, 1996; Ballard,
Davis, Cullen, Moran, & Dean, 1994). EPDS have a good acceptability and is considered as a
comfortable screening tool as the result of Gemmil, Leigh, Ericksen, and Milgrom (2006).
Gemmil and colleagues (2006) conducted a survey to find the acceptability of the EDPS
postpartum screening tool, 479 out of 920 of the women responded to their survey; 97% of the
women indicated that EPDS screening was desirable, 81.2% of women rated that the screening is
comfortable to very comfortable and only 4.3% indicated that the screening is not comfortable.
Setting: Studies showed that 44 studies of PPD screening occurred in postnatal-prenatal
clinics, 15 studies in maternity clinics, and 12 in community based organizations, which lead to
the conclusion that postnatal-prenatal clinics are the best setting for performing PPD screening.
These findings are in agreement with the Seehusen, Baldwin, Runkle, Clark, and Seehusen
(2005) findings which showed that 70.2% of physicians always or often screened for PPD at
postpartum gynecologic examinations, and 46% always or often screened mothers at well-child
visits.
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Studies were contracted worldwide, in Asia, Africa, Europe, America; Despite the
geographic variation, overall the studies did not show s, a big change in PPD screening practices.
The most commonly used instrument was EPDS, the administration period was around 6 weeks
and the PPD rate had a very small variation among the different studies. It has been inferred that
the geographic distribution is not affecting the PPD screening practices; however more studies
have been conducted in the USA that focus on BDI, PHQ-9 and PPDS comparing to other
countries where the focus was on EDPS.
Administration period: According to the DSM-4 definition, PPD is the major
depression that begins in the first four week of delivery, but according to the CDI-10 definition,
it is the major depression that begins within six weeks of delivery.
Most of the studies had been conducted 6 weeks postnatal and they gave a PPD
prevalence rate similar to the PPD worldwide rate of 5%-20% (Miller, 2002). However, other
studies were started as early as the first day of delivery (Flynn, 2005) or two weeks after delivery
(Chardon, 2007) which could explain the high rate of PPD for those studies (73% and 37%
respectively). It has been concluded from the study that the best time for applying the PPD
screening instrument is around 6 weeks postnatal; earlier than six weeks more false cases can be
detected as the new mother is trying to adapt to the new baby and also due to the tiredness and
lack of sleep the mother experiences early in the confinement period. If the screening is later
than six weeks it will be considered as a screening for major depression, not for PPD.
Cut-off points: Cut off score is very essential for the screening purpose. The purpose of
this study was to find a recommended cut-off score for best PPD screening practices. At this cut
off scores there should be a balance between the sensitivity and specificity, so the test wouldn’t
lose its value either by having high false positive cases if the sensitivity is very high, or by
having false negative cases if the specificity is very high. The screening tool that had been
chosen is EDPS, the recommended cut-off score for EDPS is 10 (Cox et al., 1987). The results
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showed inconsistency in the mean values of sensitivities and specificities as the corresponding
cut- scores changes, and it could not find an optimal cut-off score to be recommended as the best
value for screening. Our finding is consistent with other studies’ findings showing variability in
the optimal cut-off scores between population studies (Buist et al., 2002; Fergerson, Jamieson, &
Lindsay, 2002; Nishimura & Ohashi, 2010).
Conclusion and Recommendations
The rate of PPD and its screening practices are similar worldwide. Screening for PPD
using EPDS as a screening tool with the recommended cut-off point in each study population,
and having an administration period around the six weeks postnatal at perinatal clinics could be
considered as best practices for PPD.
There is a need for more future studies that can find the best practices for PPD within
each country with respect to the PPD rate, the cost-effectiveness, the availability and distribution
of perinatal clinics and the expertise in each center.
Limitations of the Study
This is a review study that compared different studies conducted worldwide, there are
limitations to this study: 1. Variation in geographic location had been ignored also the cultural
differences had not been accounted. 2. Small sample sizes of some reviewed studies. 3.
Differences in the definition of postpartum depression between the articles.
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Appendix 4 – List of Public Health Competencies Met
Specific Competencies
Domain #1: Analytic Assessment Skill
Defines a problems
Determines appropriate uses and limitations of both quantitative and qualitative data
Selects and defines variables relevant to defined public health problems
Identifies relevant and appropriate data and information sources
Evaluates the integrity and comparability of data and identifies gaps in data sources
Makes relevant inferences from quantitative and qualitative data
Obtains and interprets information regarding risks and benefits to the community
Applies data collection processes, information technology applications, and computer systems
storage/retrieval strategies
Recognizes how the data illuminates ethical, political, scientific, economic, and overall public
health issues
Domain #2: Policy Development/Program Planning Skills
Collects, summarizes, and interprets information relevant to an issue
Domain #3: Communication Skills
Communicates effectively both in writing and orally, or in other ways
Effectively presents accurate demographic, statistical, programmatic, and scientific information
for professional and lay audiences
Attitudes
Listens to others in an unbiased manner, respects points of view of others, and promotes the
expression of diverse opinions and perspectives
Domain #4: Cultural Competency Skills
Identifies the role of cultural, social, and behavioral factors in determining the delivery of public
health services
Attitudes
Understands the dynamic forces contributing to cultural diversity
Domain #5: Community Dimensions of Practice Skills
Develops, implements, and evaluates a community public health assessment
Domain #6: Basic Public Health Sciences Skills
Defines, assesses, and understands the health status of populations, determinants of health and
illness, factors contributing to health promotion and disease prevention, and factors influencing
the use of health services
Understands the historical development, structure, and interaction of public health and health
care systems
Identifies and applies basic research methods used in public health
Applies the basic public health sciences including behavioral and social sciences, biostatistics,
epidemiology, environmental public health, and prevention of chronic and infectious diseases
and injuries
Identifies and retrieves current relevant scientific evidence
Identifies the limitations of research and the importance of observations and interrelationships
Attitudes
Develops a lifelong commitment to rigorous critical thinking
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Domain #8: Leadership and Systems Thinking Skills
Helps create key values and shared vision and uses these principles to guide action
Identifies internal and external issues that may impact delivery of essential public health services
(i.e. strategic planning)
Contributes to development, implementation, and monitoring of organizational performance
standards
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